211 related articles for article (PubMed ID: 10775617)
1. Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5' nontranslated region.
Dunn JJ; Chapman NM; Tracy S; Romero JR
J Virol; 2000 May; 74(10):4787-94. PubMed ID: 10775617
[TBL] [Abstract][Full Text] [Related]
2. The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5' nontranslated region.
Tu Z; Chapman NM; Hufnagel G; Tracy S; Romero JR; Barry WH; Zhao L; Currey K; Shapiro B
J Virol; 1995 Aug; 69(8):4607-18. PubMed ID: 7609025
[TBL] [Abstract][Full Text] [Related]
3. The stem loop II within the 5' nontranslated region of clinical coxsackievirus B3 genomes determines cardiovirulence phenotype in a murine model.
Dunn JJ; Bradrick SS; Chapman NM; Tracy SM; Romero JR
J Infect Dis; 2003 May; 187(10):1552-61. PubMed ID: 12721935
[TBL] [Abstract][Full Text] [Related]
4. Genomic regions of coxsackievirus B3 associated with cardiovirulence.
Lee C; Maull E; Chapman N; Tracy S; Gauntt C
J Med Virol; 1997 Jul; 52(3):341-7. PubMed ID: 9210047
[TBL] [Abstract][Full Text] [Related]
5. A single amino acid substitution in the capsid protein VP1 of coxsackievirus B3 (CVB3) alters plaque phenotype in Vero cells but not cardiovirulence in a mouse model.
Zhang H; Blake NW; Ouyang X; Pandolfino YA; Morgan-Capner P; Archard LC
Arch Virol; 1995; 140(5):959-66. PubMed ID: 7605207
[TBL] [Abstract][Full Text] [Related]
6. Sites other than nucleotide 234 determine cardiovirulence in natural isolates of coxsackievirus B3.
Chapman NM; Romero JR; Pallansch MA; Tracy S
J Med Virol; 1997 Jul; 52(3):258-61. PubMed ID: 9210033
[TBL] [Abstract][Full Text] [Related]
7. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3.
Knowlton KU; Jeon ES; Berkley N; Wessely R; Huber S
J Virol; 1996 Nov; 70(11):7811-8. PubMed ID: 8892902
[TBL] [Abstract][Full Text] [Related]
8. Genetics of coxsackievirus B3 cardiovirulence.
Tracy S; Tu Z; Chapman N; Hufnagel G
Eur Heart J; 1995 Dec; 16 Suppl O():15-7. PubMed ID: 8682085
[TBL] [Abstract][Full Text] [Related]
9. Attenuating mutations in coxsackievirus B3 map to a conformational epitope that comprises the puff region of VP2 and the knob of VP3.
Stadnick E; Dan M; Sadeghi A; Chantler JK
J Virol; 2004 Dec; 78(24):13987-4002. PubMed ID: 15564506
[TBL] [Abstract][Full Text] [Related]
10. Characterization of an infectious cDNA copy of the genome of a naturally occurring, avirulent coxsackievirus B3 clinical isolate.
Lee CK; Kono K; Haas E; Kim KS; Drescher KM; Chapman NM; Tracy S
J Gen Virol; 2005 Jan; 86(Pt 1):197-210. PubMed ID: 15604447
[TBL] [Abstract][Full Text] [Related]
11. Molecular analysis of the role of IRES stem-loop V in replicative capacities and translation efficiencies of Coxsackievirus B3 mutants.
M'hadheb-Gharbi MB; Kean KM; Gharbi J
Mol Biol Rep; 2009 Feb; 36(2):255-62. PubMed ID: 18027104
[TBL] [Abstract][Full Text] [Related]
12. Coxsackievirus B3 clinical isolates and murine myocarditis.
Gauntt CJ; Pallansch MA
Virus Res; 1996 Mar; 41(1):89-99. PubMed ID: 8725105
[TBL] [Abstract][Full Text] [Related]
13. Attenuation of a reactivated cardiovirulent coxsackievirus B3: The 5'-nontranslated region does not contain major attenuation determinants.
Zhang HY; Yousef GE; Cunningham L; Blake NW; OuYang X; Bayston TA; Kandolf R; Archard LC
J Med Virol; 1993 Oct; 41(2):129-37. PubMed ID: 8283174
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of genomic RNA of Coxsackievirus B3 in murine myocarditis: reliability of direct sequencing of reverse transcription-nested polymerase chain reaction products.
Zhang H; Soteriou B; Knowlson S; Theodoridou A; Archard LC
J Virol Methods; 1997 Dec; 69(1-2):7-17. PubMed ID: 9504746
[TBL] [Abstract][Full Text] [Related]
15. An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses.
Chapman NM; Tu Z; Tracy S; Gauntt CJ
Arch Virol; 1994; 135(1-2):115-30. PubMed ID: 8198437
[TBL] [Abstract][Full Text] [Related]
16. Group B coxsackievirus myocarditis and pancreatitis: connection between viral virulence phenotypes in mice.
Tracy S; Höfling K; Pirruccello S; Lane PH; Reyna SM; Gauntt CJ
J Med Virol; 2000 Sep; 62(1):70-81. PubMed ID: 10935991
[TBL] [Abstract][Full Text] [Related]
17. Structure of the 5' nontranslated region of the coxsackievirus b3 genome: Chemical modification and comparative sequence analysis.
Bailey JM; Tapprich WE
J Virol; 2007 Jan; 81(2):650-68. PubMed ID: 17079314
[TBL] [Abstract][Full Text] [Related]
18. Coxsackievirus B3 induces apoptosis in the early phase of murine myocarditis: a comparative analysis of cardiovirulent and noncardiovirulent strains.
Joo CH; Hong HN; Kim EO; Im JO; Yoon SY; Ye JS; Moon MS; Kim D; Lee H; Kim YK
Intervirology; 2003; 46(3):135-40. PubMed ID: 12867750
[TBL] [Abstract][Full Text] [Related]
19. Mutation variants generated from nonvirulent coxsackievirus B3 acquire virulence phenotypes by active virus replication.
Seo I; Jee Y; Ahn J; Jun EJ; Kim D; Joo CH; Kim YK; Lee H
Intervirology; 2007; 50(6):447-53. PubMed ID: 18268408
[TBL] [Abstract][Full Text] [Related]
20. A non-cardiovirulent strain of coxsackievirus B3 causes myocarditis in mice with severe combined immunodeficiency syndrome.
Hufnagel G; Chapman N; Tracy S
Eur Heart J; 1995 Dec; 16 Suppl O():18-9. PubMed ID: 8682092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]